EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluating the performance of anal cytology and high‐risk HPV genotyping for detecting anal HSIL in a clinic‐based sample of people living with and without HIV in Puerto Rico

Jeslie M Ramos-Cartagena iD, Kandyce Keller, Humberto M Guiot, Cristina Muñoz, Vivian Colón-López, Ashish A Deshmukh, Erick L Suárez, Maribel Tirado-Gómez, Ana P Ortiz

Cancer Cytopathology · 2023

DOI: 10.1002/cncy.22738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2023. Verfasst von Jeslie M Ramos-Cartagena und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico. Hauptthemen laut MEDLINE: Papillomavirus Infections, Squamous Intraepithelial Lesions, HIV Infections, Anus Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Given the disproportionately elevated anal cancer risk in high‐risk populations, it is important to assess the performance of commonly used anal cancer screening tools to improve the effectiveness of detection and treatment methods. This study evaluates 1) the concordance between anal cytology and histology results and 2) the performance of cytology and high‐risk human papillomavirus (HR‐HPV) genotyping as screening tools for detecting histologically confirmed anal high‐grade squamous intraepithelial lesions (HSIL).

Methods

Data from the Anal Neoplasia Clinic in Puerto Rico (2014–2021; n = 466) was used. The clinical performance of anal cytology and HR‐HPV genotyping to detect HSIL was compared to the gold standard: high‐resolution anoscopy‐guided biopsy. Sensitivity, specificity, positive predictive value, negative predictive value, and κ coefficients were calculated.

Results

A total of 66.95% of the patients were men, 74.0% were people living with HIV, 76.2% had anal HR‐HPV infection, and 40.34% had histologically confirmed anal HSIL. The weighted κ statistic between the tests (cytology and histology) was 0.25 ( p < .001). The sensitivity and specificity of cytology alone to detect anal HSIL were 84.3% (95% confidence interval [CI], 78.3%–89.1%) and 36.0% (95% CI, 30.3%–42.0%), respectively. Anal HR‐HPV genotyping had higher sensitivity (92.2%; 95% CI, 87.4%–95.6%) and similar specificity (34.8%; 95% CI, 29.2%–40.7%) compared to cytology. The two tests combined (positive results following cytology or HR‐HPV test) improved sensitivity to detect anal HSIL (97.9%; 95% CI, 94.8%–99.4%), but specificity was compromised (19.2%; 95% CI, 14.7%–24.4%).

Conclusion

Although HR‐HPV genotyping improved the detection of anal HSIL, HR‐HPV testing had lower specificity than anal cytology alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsSquamous Intraepithelial LesionsHIV InfectionsAnus NeoplasmsMaleHumansFemalePuerto RicoGenotypeRisk FactorsPapillomaviridae

Stichwörter der Autor:innen

HR-HPV genotypingHR-HPV infectionHR-HPV testPuerto Ricoanal cancer screeninganal cytologyhigh-grade squamous intraepithelial lesions

Autor:innen und Institutionen

  • University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
  • University of Michigan, Ann Arbor, Michigan, USA.
  • School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
  • Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID-Profile: Jeslie M Ramos-Cartagena

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Ramos-Cartagena, J. M., Keller, K., Guiot, H. M., Muñoz, C., Colón-López, V., Deshmukh, A. A., Suárez, E. L., Tirado-Gómez, M., & Ortiz, A. P. (2023). Evaluating the performance of anal cytology and high‐risk HPV genotyping for detecting anal HSIL in a clinic‐based sample of people living with and without HIV in Puerto Rico. Cancer Cytopathology. https://doi.org/10.1002/cncy.22738

Vancouver

Ramos-Cartagena JM, Keller K, Guiot HM, Muñoz C, Colón-López V, Deshmukh AA, et al. Evaluating the performance of anal cytology and high‐risk HPV genotyping for detecting anal HSIL in a clinic‐based sample of people living with and without HIV in Puerto Rico. Cancer Cytopathology. 2023. doi:10.1002/cncy.22738

BibTeX
@article{RamosCartagena2023,
  author = {Ramos-Cartagena, Jeslie M and Keller, Kandyce and Guiot, Humberto M and Muñoz, Cristina and Colón-López, Vivian and Deshmukh, Ashish A and Suárez, Erick L and Tirado-Gómez, Maribel and Ortiz, Ana P},
  title = {Evaluating the performance of anal cytology and high‐risk HPV genotyping for detecting anal HSIL in a clinic‐based sample of people living with and without HIV in Puerto Rico},
  journal = {Cancer Cytopathology},
  year = {2023},
  doi = {10.1002/cncy.22738}
}
Kostenlos starten →